Computed Tomography Angiography (CTA) of the Chest in Patients with Impaired Renal Function

Risk Assessment and Prevention

The American College of Radiology recommends that CTA of the chest can generally be performed with caution when eGFR is above 30 mL/min/1.73 m², but should be avoided when eGFR falls below 30 mL/min/1.73 m² due to increased risk of contrast-induced nephropathy 1, 2, 3
For patients with eGFR > 45 mL/min/1.73 m², intravenous contrast administration for CTA carries minimal risk of clinically relevant contrast-induced nephropathy (CIN) 1, 2
For patients with eGFR between 30-45 mL/min/1.73 m², CTA can be performed with appropriate precautions, though there are conflicting results regarding CIN risk in this group 1, 2
For patients with eGFR < 30 mL/min/1.73 m², CTA with iodinated contrast is generally contraindicated due to significantly increased risk of acute kidney injury 1, 2, 3

For patients with eGFR < 30 mL/min/1.73 m², the American College of Radiology recommends considering alternative imaging approaches, such as duplex Doppler ultrasound, which is the preferred initial imaging modality for patients with severe renal impairment (rated 9/9 in appropriateness) 3
Non-contrast MRA is an appropriate alternative (rated 7/9 in appropriateness) when ultrasound is insufficient 3

The European Heart Journal recommends minimizing contrast volume (keeping total contrast volume/GFR < 3.4) when CTA must be performed in patients with borderline renal function (eGFR 30-45 mL/min/1.73 m²) 4
Providing hydration with isotonic saline before and after the procedure is also recommended 4
Considering using iso-osmolar contrast media rather than low-osmolar contrast media is advised 4
Short-term, high-dose statin therapy (e.g., rosuvastatin 40/20 mg, atorvastatin 80 mg, or simvastatin 80 mg) may also be considered 4

Diabetes mellitus may necessitate more caution even at higher eGFR levels 5
Concomitant nephrotoxic medications, multiple recent contrast exposures, and dehydration may also increase the risk of contrast-induced nephropathy 4
Monitoring renal function by measuring serum creatinine and calculating eGFR 48-72 hours after contrast administration is recommended for patients with borderline renal function who undergo CTA 1
Being alert for signs of acute kidney injury (oliguria, edema, rising creatinine) is crucial 1

Relying solely on serum creatinine rather than eGFR for risk assessment (eGFR is a better indicator of baseline renal function) is a common pitfall 1, 2
Failing to adequately hydrate patients before and after contrast administration is also a common mistake 4
Using excessive contrast volumes in at-risk patients should be avoided 4
Not considering alternative imaging modalities in patients with severe renal impairment is another pitfall to avoid 3